Literature DB >> 26126029

Platelet disorders: an overview.

Manasa Krishnegowda1, Vani Rajashekaraiah.   

Abstract

Thrombocytes or platelets are anucleated cells derived from megakaryocytes by process of megakaryopoiesis, with maturation time of 4-5 days. They are small and discoid in shape with size ranging from 2 to 4 μm. The platelet concentration in blood varies between 150, 000 and 400, 000  cells/μl of blood. They are involved in both hemostasis and wound healing. Hence, any abnormalities in platelets can lead to various bleeding disorders. Platelet disorders include thrombocythemia and thrombocytosis, thrombocytopenia and platelet dysfunction. Thrombocythemia and thrombocytosis are associated with increased platelet count because of overproduction of platelets. Thrombocytopenia includes decreased platelet count because of failed platelet production, increased sequestration of platelets in spleen, dilution of platelets and combination of these mechanisms. Platelet dysfunction can be because of intrinsic platelet defect or an extrinsic factor that alters the normal platelet function and can be hereditary or acquired. The following review provides a comprehensive overview of the above platelet disorders.

Entities:  

Mesh:

Year:  2015        PMID: 26126029     DOI: 10.1097/01.mbc.0000469521.23628.2d

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

1.  Platelet-like particles improve fibrin network properties in a hemophilic model of provisional matrix structural defects.

Authors:  Seema Nandi; Laura Sommerville; Kimberly Nellenbach; Emily Mihalko; Mary Erb; Donald O Freytes; Maureane Hoffman; Dougald Monroe; Ashley C Brown
Journal:  J Colloid Interface Sci       Date:  2020-05-26       Impact factor: 8.128

2.  MicroRNA-26b Attenuates Platelet Adhesion and Aggregation in Mice.

Authors:  Linsey J F Peters; Constance C F M J Baaten; Sanne L Maas; Chang Lu; Magdolna Nagy; Natalie J Jooss; Kiril Bidzhekov; Donato Santovito; Daniel Moreno-Andrés; Joachim Jankowski; Erik A L Biessen; Yvonne Döring; Johan W M Heemskerk; Christian Weber; Marijke J E Kuijpers; Emiel P C van der Vorst
Journal:  Biomedicines       Date:  2022-04-23

3.  Platelet heterogeneity enhances blood clot volumetric contraction: An example of asynchrono-mechanical amplification.

Authors:  Yueyi Sun; David R Myers; Svetoslav V Nikolov; Oluwamayokun Oshinowo; John Baek; Samuel M Bowie; Tamara P Lambert; Eric Woods; Yumiko Sakurai; Wilbur A Lam; Alexander Alexeev
Journal:  Biomaterials       Date:  2021-04-23       Impact factor: 15.304

4.  DMAG, a novel countermeasure for the treatment of thrombocytopenia.

Authors:  Jing Lin; Jing Zeng; Sha Liu; Xin Shen; Nan Jiang; Yue-Song Wu; Hong Li; Long Wang; Jian-Ming Wu
Journal:  Mol Med       Date:  2021-11-27       Impact factor: 6.354

5.  Synthetic platelet microgels containing fibrin knob B mimetic motifs enhance clotting responses.

Authors:  Seema Nandi; Emily Mihalko; Kimberly Nellenbach; Mario Castaneda; John Schneible; Mary Harp; Halston Deal; Michael Daniele; Stefano Menegatti; Thomas H Barker; Ashley C Brown
Journal:  Adv Ther (Weinh)       Date:  2021-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.